Summary
Centene Corporation (CNC) has filed an 8-K report detailing the completion of a $1.8 billion underwritten public offering of 2.450% Senior Notes due 2028. The primary purpose of this offering is to finance a portion of the cash consideration required for Centene's previously announced acquisition of Magellan Health Inc. The closing of the note offering is not contingent on the completion of the Magellan acquisition, providing Centene with capital flexibility. If the acquisition does not proceed, the net proceeds will be allocated to debt repayment and general corporate purposes. These senior unsecured notes rank equally with existing and future senior indebtedness, and are senior to subordinated debt, but effectively junior to secured indebtedness. The notes carry a maturity date of July 15, 2028, with semi-annual interest payments. The company retains the option to redeem the notes under specific conditions, including a change of control provision that would trigger a mandatory offer to purchase the notes at 101% of the principal amount. This financing move is a significant step in Centene's strategic growth plans, particularly its pursuit of the Magellan Health acquisition.
Key Highlights
- 1Centene Corporation completed a $1.8 billion offering of 2.450% Senior Notes due 2028.
- 2Proceeds are intended to finance the acquisition of Magellan Health Inc.
- 3The note offering's closing is independent of the Magellan acquisition's closing.
- 4If the acquisition fails, proceeds will be used for debt repayment and general corporate purposes.
- 5The notes are senior unsecured obligations, maturing on July 15, 2028.
- 6Redemption options exist, including a change of control provision triggering a 101% purchase offer.
- 7The offering was made under an effective automatic shelf registration statement on Form S-3ASR.